Invesco’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $812K | Buy |
113,060
+44,317
| +64% | +$318K | ﹤0.01% | 2937 |
|
|
2025
Q1 | $412K | Buy |
68,743
+30,102
| +78% | +$180K | ﹤0.01% | 3218 |
|
|
2024
Q4 | $301K | Sell |
38,641
-455,437
| -92% | -$3.55M | ﹤0.01% | 3398 |
|
|
2024
Q3 | $5.34M | Buy |
494,078
+330,112
| +201% | +$3.57M | ﹤0.01% | 2176 |
|
|
2024
Q2 | $1.38M | Buy |
163,966
+127,124
| +345% | +$1.07M | ﹤0.01% | 2773 |
|
|
2024
Q1 | $248K | Buy |
36,842
+2,102
| +6% | +$14.1K | ﹤0.01% | 3566 |
|
|
2023
Q4 | $204K | Buy |
34,740
+2,066
| +6% | +$12.1K | ﹤0.01% | 3554 |
|
|
2023
Q3 | $319K | Buy |
32,674
+1,363
| +4% | +$13.3K | ﹤0.01% | 3415 |
|
|
2023
Q2 | $371K | Buy |
31,311
+3,697
| +13% | +$43.8K | ﹤0.01% | 3391 |
|
|
2023
Q1 | $298K | Buy |
27,614
+9,999
| +57% | +$108K | ﹤0.01% | 3487 |
|
|
2022
Q4 | $204K | Sell |
17,615
-439,868
| -96% | -$5.08M | ﹤0.01% | 3658 |
|
|
2022
Q3 | $6.83M | Sell |
457,483
-436,109
| -49% | -$6.51M | ﹤0.01% | 2026 |
|
|
2022
Q2 | $8.06M | Buy |
893,592
+881,334
| +7,190% | +$7.95M | ﹤0.01% | 1983 |
|
|
2022
Q1 | $92K | Buy |
12,258
+459
| +4% | +$3.45K | ﹤0.01% | 3836 |
|
|
2021
Q4 | $102K | Sell |
11,799
-336
| -3% | -$2.91K | ﹤0.01% | 3863 |
|
|
2021
Q3 | $102K | Sell |
12,135
-717,711
| -98% | -$6.03M | ﹤0.01% | 3905 |
|
|
2021
Q2 | $5.92M | Buy |
729,846
+26,762
| +4% | +$217K | ﹤0.01% | 2356 |
|
|
2021
Q1 | $6.17M | Buy |
703,084
+3,084
| +0.4% | +$27.1K | ﹤0.01% | 2262 |
|
|
2020
Q4 | $7.86M | Buy |
+700,000
| New | +$7.86M | ﹤0.01% | 1930 |
|